FRESH-PEF73838-en
Prospective analysis of morbi-mortality of patients with cancers in active phase of treatment suspected or diagnosed of a SARS-CoV-2 infection
ONCOVID-19
| Name | Country code |
|---|---|
| France | fr |
['Clinical data']
Individuals
| Topic | Vocabulary |
|---|---|
| Oncology | health theme |
| Neoplasms | cim-11 |
| COVID-19 | cim-11 |
{
"level_sex_clusion_I": [
{
"value": "Male",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008297"
}
},
{
"value": "Female",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D005260"
}
}
],
"level_age_clusion_I": [
{
"value": "Young Adult (19 to 24 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D055815"
}
},
{
"value": "Adult (25 to 44 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000328"
}
},
{
"value": "Middle Aged (45 to 64 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008875"
}
},
{
"value": "Aged (65 to 79 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000368"
}
},
{
"value": "Aged, 80 and over (80 years and more)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000369"
}
}
],
"level_type_clusion_I": [
"Patients population"
],
"level_type_clusion_other": "",
"clusion_I": "Confirmed diagnosis of any type of solid or hematologic tumor; - Ongoing anticancer treatment (cytotoxic, targeted therapy, immunotherapy or loco regional procedure, including radiotherapy, surgery or interventional radiology procedure) at the time of inclusion or within the last 3 months prior to inclusion (last treatment administration or last loco regional procedure) ; - Patient with suspicion of COVID-19 (clinical symptoms of COVID-19 including fever (>38°C) and\/or respiratory tract symptoms), either confirmed or not. Note 1: Patients must have underwent diagnostic procedures: diagnostic test (positive or negative) and\/or chest imaging. Note 2: Patients will be eligible regardless of the presence of a neutropenia (either febrile or not) - Patient and\/or family did not decline data collection after complete information (information sheet)",
"clusion_E": ""
}
| Name |
|---|
| Souad;ASSAAD |
| Name | Role |
|---|---|
| CENTRE LEON BERARD | sponsor |
| Name |
|---|
| AGENCE NATIONALE DE LA RECHERCHE (ANR) |
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Observational Study
| Start | End |
|---|---|
| 2020-01-01 | 2020-12-31 |
['Remote monitoring']
{"value":"To be defined","extLink":[]}
FRESH-PEF73838-en
| Name | Affiliation |
|---|---|
| JULIEN GAUTIER | UNICANCER GROUP |